quire changes in p57 protein levels to undergo differentiation.
differs as this cell type has a very limited capacity for and the establishment of a mature phenotype, and p57 is excell division [2] [3] [4] . Studies in both animal models and pressed exclusively in podocytes in mature glomeruli. Howhuman disease suggest that while the podocyte is capable ever, p57 knockout mice have normal glomerular podocyte of DNA synthesis, the replicative process may stall after development. In addition, mRNA but not protein levels of p57 increased upon differentiation of podocytes in vitro. There was mitosis resulting in nuclear polyploidy and cell hypertroa marked decrease in p57 expression in both animal models phy without an increase in podocyte number [5, 6] . Eviof podocyte injury. This was diffuse in PHN, whereas in the dence suggests that this failure to divide may account murine model, loss of expression of p57 occurred predomifor the relentless process of glomerulosclerosis leading nantly in proliferating podocytes, expressing proliferating cell nuclear antigen (PCNA).
to irreversible renal failure [7] .
Conclusion. Despite the de novo expression of p57 protein
Primordial and immature podocytes freely enter the coinciding with the cessation of primitive podocyte proliferacell cycle and proliferate during embryogenesis [8] . Mation during glomerulogenesis, embryonic p57Ϫ/Ϫ mice glomerture podocytes then exit the cell cycle in order to take uli were histologically normal. Cultured podocytes did not reon a terminally differentiated phenotype [9] . Mature podocytes, however, may re-engage the cell cycle in certain [12] . Thereafter, cells pass through G 2 into the final M murine nephrogenesis, in cell culture, and in experimental models of glomerular disease. Our results show that (mitotic) phase, followed by cytokinesis. Recently it has been appreciated that the cell cycle is a tightly regulated although p57 expression coincides with podocyte exit from the cell cycle during glomerulogenesis, p57Ϫ/Ϫ process dependent on both positive and negative regulatory influences [13, 14] . Cyclins and their catalytic submice have a normal glomerular architecture. We also show that the mRNA levels for p21 and p27, p57 inunits cyclin dependent kinases (CDKs) constitute the major positive regulatory proteins [15] . During each creased in cultured podocytes during differentiation. Finally, our results show that injury to podocytes in vivo phase of the cell cycle, there is increased expression of specific cyclins. Thus, D-type cyclins are expressed early is associated with a decrease in p57 expression, which alone is not sufficient to induce podocyte proliferation. in G 1 , cyclin E in late G 1 , cyclin A in G 1 /S, and cyclin B in the M phase. Cyclins bind to and activate specific CDKs. D-cyclins bind to CDK4, whereas cyclins E and METHODS A bind to CDK2. Cyclin B binds to cdc2 (formally called
In vivo studies CDK1). In turn, active CDKs phosphorylate certain target genes required for DNA synthesis, such as pRB [15] .
Kidney development. To determine the temporal expression of p57 during podocyte development, embryThe cell cycle also is negatively regulated by a group of proteins known as cyclin kinase inhibitors (CKI) [14] .
onic kidneys of gestational ages embryonic day 15 (E15; N ϭ 5), E18 (N ϭ 5), and E21 (N ϭ 4) were harvested CKI cause cell cycle arrest by binding to and inhibiting specific cyclin-CDK complexes. The Cip/Kip family of from gravid C57BL6 mice (Simonsen, Gilroy, CA, USA). Additional kidneys were removed from mice sacrificed CKI, consisting of p21 CIP1, WAF1, SDI1 (p21), p27 KIP1 (p27), and p57 KIP2 (p57), which inhibit both G 1 and S phase at days 1 (N ϭ 10), 3 (N ϭ 9), 5 (N ϭ 9), 7 (N ϭ 8), 14 (N ϭ 8), and 28 (N ϭ 8) following birth. In a separate cyclin-CDK complexes, have been best studied with regard to their role in glomerular disease [16, 17] . In particexperiment, two gravid mice of gestational age E15 were injected with intraperitoneal 5-bromo-2Ј-deoxyuridine ular, we have shown that the dramatic mesangioproliferative response following complement-mediated injury (BrdU, 10 L/g; Amersham Life Science, Arlington Heights, IL, USA) four hours prior to sacrifice. All kidin the Thy1 model is associated with down-regulated expression of p27 [18] . In contrast, in the passive Heyneys were fixed in methyl Carnoy's solution for immunohistochemistry. mann nephritis model of membranous nephropathy, injury to the podocyte is associated with up-regulation of To determine the role of p57 during glomerulogenesis, p57 heterozygotes (on a C57BL6 background) were bred the CKI p21 and p27 [19] Studies of nephritic p21 and p27 knockout mice have further supported a role for to generate p57 null (p57Ϫ/Ϫ) and wild-type (p57ϩ/ϩ) offspring as previously reported [32] . Heterozygote gesthese CKI in limiting podocyte proliferation [20, 21] .
The most recently identified member among the Cip/ tational female mice were injected with 10 L/g BrdU (Amersham) four hours prior to sacrifice. Embryonic Kip family of CKIs is p57. Named according to its molecular weight, p57 is a 57 kD protein that inhibits cell cycle kidneys were removed on days E15 and E18 and fixed in methyl Carnoy's solution to study glomerular morprogression by binding to CDK2, -3, and -4 [22, 23] . Overexpressing p57 leads to G 1 phase cell cycle arrest phology and cellularity in p57 null and wild-type mice (N ϭ 3 per time point/group), which were identified [22, 23] . Mouse p57 exhibits unique protein domains (proline-rich and acidic) that are structurally distinct by standard genotyping. Attempts were made to study postnatal glomerulogenesis, but no p57 null mice surfrom those common to p21 and p27 [23] . In contrast to the widespread tissue expression of p21 [24] and p27 vived to birth [33] . Experimental model of podocyte injury in the rat. To [25] , p57 demonstrates a more restrictive distribution in placenta, muscle, heart, brain, lung and kidney [22, 23] .
examine the expression of p57 in vivo following podocyte injury that is characterized by an absence of podocyte prop57 has been implicated in the process of cell cycle exit accompanying terminal differentiation of a variety of liferation, the passive Heymann nephritis (PHN) model of membranous nephropathy (a model devoid of podonon-renal cells including lens fibers [26, 27] , myoblasts [28] , and keratinocytes [29] . cyte proliferation) was studied. PHN was induced in male Sprague-Dawley rats Simonsen) by the intraWe [30] and others [31] have previously reported that p57 is constitutively expressed in mature podocytes. Yet peritoneal injection (5 mL/kg) of sheep antibody to Fx1A [34] . A control group consisted of rats receiving normal the role of this CKI in the regulation of podocyte maturation and proliferation, and in glomerular disease has not sheep serum. Control and PHN animals were sacrificed on days 5 (N ϭ 6 per group), 10 (N ϭ 5 per group) and been clearly defined. Accordingly, to explore the possibility that p57 is a critical regulator of podocyte prolifera-30 (N ϭ 6 per group) following disease induction. Experimental model of podocyte proliferation in the tion and differentiation during development and in disease, we examined the protein expression of p57 during mouse. In order to correlate p57 expression with podo-cyte proliferation in vivo, immune-mediated glomerular (33ЊC and media supplemented with mouse ␥-interferon 50 units/mL), they readily proliferate and maintain a uniinjury was induced in C57/BL6 mice (Simonsen) by the intraperitoneal injection of sheep anti-rabbit glomerular form, cobblestone morphology (referred to as "growth permissive" in this article). In contrast, podocytes grown antibody (0.5 mL/20 g body weight) on two consecutive days, as previously described [20, 34] . This model is charunder differentiating conditions (37ЊC, no interferon) stop proliferating, and elaborate a complex network of acterized by low-grade glomerular epithelial cell proliferation [20, 34] . Mice receiving normal sheep serum processes. This transformation to an "arborized" phenotype (referred to as the "differentiating" phenotype) is served as controls. Kidneys were harvested on day 7 following disease induction (N ϭ 6 per group).
associated with a marked diminution in DNA synthesis, and the de novo expression of synaptopodin, a marker Immunohistochemistry. Kidneys from rats or mice were fixed in methyl Carnoy's solution, processed and embedof mature podocytes [38] . Growth permissive and differentiating HSMP were ded in paraffin using conventional techniques. Two-micrometer thin sections were stained for p57 using the avidin/ grown on plastic in RPMI (Gibco BRL, Gaithersburg, MD, USA) supplemented with 10% fetal calf serum biotin indirect immunoperoxidase method as previously described [18] . In brief, sections were incubated over- (FCS) . Recombinant mouse ␥-interferon (Coulter) was added only to growth permissive media at a concentranight with the primary antibody M20 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), a goat polyclonal IgG tion of 50 U/mL. Cells from passages 11 to 19 were used for all experiments, which were performed a total of four that recognizes an epitope mapping to the amino terminus of mouse p57. The specificity of the p57 antibody times. Except where noted, studies were performed on cells at day 3 following passage in growth permissive was verified by Western blotting wherein the primary antibody was mixed with serial dilutions of a p57 blocking conditions, and at days 3 and 8 following passage into differentiating conditions. peptide (Santa Cruz). This was followed by a secondary biotinylated rabbit antigoat IgG (Zymed, San Francisco, BrdU, WT-1, and synaptopodin staining in vitro. 5-Bromo-2Ј-deoxyuridine incorporation into DNA was used CA, USA) and horseradish peroxidase streptavidin (Vector, Burlingame, CA, USA). To determine if p57 immuas a measure of DNA synthesis. Cells were passaged and grown in chamber slides (50,000 cells/well) under growth nostaining colocalized with DNA synthesis, sequential sections also were stained for the DNA synthesis markpermissive and differentiating conditions. On sequential days following passage (days 2 to 9), cells were incubated ers proliferating cell nuclear antigen (PCNA) and BrdU. For PCNA staining, we used the primary antibody 19A2, for four hours in serum free media containing BrdU (Amersham) at a concentration of 1:500. Cells were then a murine IgM (Coulter, Hialeah, FL, USA), followed by an HRP-Rat antimouse IgM (Zymed); for BrdU staining, fixed in a 1:1 mixture of methanol and acetone for 15 minutes at Ϫ20ЊC. Immunofluorescent staining for BrdU the primary and secondary antibodies contained within the Amersham cell proliferation kit (Amersham) were used was carried out using the nuclease and primary antibody contained in the Amersham cell proliferation kit (Amerin conjunction with a microwave retrieval step, as previously described [36] . Diaminobenzidine (Sigma Chemsham) with the exception that the primary antibody was used at double the concentration recommended by the icals, St. Louis, MO, USA) with (for PCNA and BrdU immunostaining) or without (for p57 immunostaining) manufacturer. This was followed by a biotinylated antimouse IgG (Vector) and streptavidin FITC (Amersham). nickel chloride was used as the detecting reagent. Negative controls consisted of omission of the primary antiCounterstain was with Hoechst 33342 (Molecular Probes, Eugene, OR, USA) at a concentration of 10 mol/L. The body, or substitution of the primary antibody with an irrelevant murine immunoglobulin.
number of BrdU positive cells per 300 Hoechst positive nuclei was recorded for each time point.
Cell culture studies
For WT-1 and synaptopodin staining, cells were grown in chamber slides under both permissive (day 3) and difConditionally immortalized mouse podocytes in cell culture: Experimental design. We used a conditionally imferentiating (day 6) conditions, and were fixed in methanol and acetone as described earlier in this article. For mortalized mouse podocyte cell line for the cell culture experiments, and have referred to these cells as heat-WT-1 staining, the primary rabbit polyclonal IgG antibody (C-19; Santa Cruz Biotechnology) was incubated sensitive mouse podocytes (HSMP) in this article. The methods for producing H-2K b -tsA58 transgenic mice overnight at 4ЊC. This was followed by a biotinylated antirabbit IgG (Vector), and streptavidin FITC (Amersham). [36] , and isolating podocytes from H-2K b -tsA58 kidneys have been described previously [37] . These mice are For synaptopodin staining, the primary antibody (generated by Dr. Peter Mundel as previously described) contransgenic for a temperature-sensitive (tsA58) SV40 large T antigen that is under control of a ␥-interferon sisted of a murine monoclonal anti-synaptopodin IgG. This was incubated overnight, followed by a biotinylated inducible promoter. When podocytes derived from these mice are cultured under growth permissive conditions antimouse IgG (Vector) and streptavidin FITC (Amer-sham). Cells were counterstained with Hoechst 33342 Western blot analysis (Molecular Probes).
The protein expression of certain cell cycle regulatory proteins was measured by Western blot analysis as preMeasuring the expression of cell cycle regulatory viously described [38] . Confluent HSMP were washed proteins in cultured cells three times with phosphate-buffered saline (PBS), and detached using a cell scraper. Following centrifugation, Quantitative real-time PCR for p21, p27 and p57. The pellets were suspended in a buffer containing 1% triton, mRNA levels of the CDK-inhibitors p21, p27 and p57 were 10% glycerol, 20 mmol/L HEPES, 100 mmol/L NaCl, and measured by real-time polymerase chain reaction (PCR) the Complete protease inhibitor tablets (Boehringer and quantitated by measuring the housekeeping gene glycMannheim, Indianapolis, IN, USA). Following a vortex, eraldehyde-3-phosphate dehydrogenase (GAPDH). To-HSMP were stored overnight at Ϫ70ЊC. The protein contal RNA was isolated from 70% confluent HSMP using centration of the supernatant was measured by the BCA the Tri-Reagent (Sigma) according to manufacturer's inprotein assay (Pierce, Rockford, IL, USA). For Western structions. Five micrograms of total RNA were converted blot analysis, HSMP protein (10 g for cyclin A, B1, into cDNA using the oligo(dT) protocol contained in the CDK2, p21, p27; 20 g for cyclin D2; 20 to 100 g for Superscript First-Strand Synthesis System for reverse p57) extract was separated under reducing conditions on transcription (RT)-PCR (Gibco BRL). Twenty-five nanoeither 8% (cyclin A, cyclin B1, p57) or 15% (CDK2, cyliters of the RT reaction (20 L) were then used as temclin D2, p21, p27) sodium dodecyl sulfate-polyacrylplate for a 50 L PCR reaction (1ϫ TaqMan Universal amide gel electrophoresis (SDS-PAGE) gels, and transMaster Mix; Applied Biosystems, Foster City, CA, USA), ferred to polyvinylidene difluoride (PVDF) membranes 200 nmol/L forward and reverse primers (100 nmol/L (Millipore, Bedford, MA, USA) by electroblotting. NonTaqMan probe) for p21, p27, p57 and GAPDH using the specific background was blocked by incubating the mem-ABI PRISM 7700 Sequence Detection System (Apbranes with 5% non-fat dried milk for 30 minutes. Blots plied Biosystems). Primers and TaqMan probes were dewere probed overnight at 4ЊC using rabbit polyclonal signed by the Primer Express 1.0 (Applied Biosystems) antibodies to cyclin A (Santa Cruz) and cyclin D2 (Santa Cruz), mouse monoclonal antibodies to CDK2, cyclin B1 as follows: p21 [forward primer, 5Ј-CCGTTGTCTCTT (Santa Cruz), p21 (Pharmingen, San Diego, CA, USA), CGGTCCC-3Ј, reverse primer, 5Ј-CATGAGCGCATC and p27 (Santa Cruz), or a goat polyclonal antibody to GCAATC-3Ј, a TaqMan probe, 5Ј-(FAM)-TGGACAG p57 (Santa Cruz). For p57, the secondary antibody con-TGAGCAGTTGCGCCG-(TAMRA)-3Ј], p27 [forward sisted of a biotinylated anti-goat IgG (Zymed) followed primer, 5Ј-TTTTCCGGAGAGAGGCGAG-3Ј, reverse by streptavidin-alkaline phosphatase (Vector). An alkaprimer, 5Ј-CTCACGTTTGACATCTTCCTCCT-3Ј, Taqline phosphatase conjugated secondary antibody (ProMan probe, 5Ј-(FAM)-CGGTGGTCCACACCCGCCCmega, Madison, WI, USA) was used in blots for all other (TAMRA)-3Ј], and p57 [forward primer, 5Ј-CAGCGGA cell cycle regulatory proteins. Protein was detected with CGATGGAAGAACT-3Ј, reverse primer, 5Ј-CTCCGG the chromagen 5-bromo-4-chloro-3-indolyl phosphate/ TTCCTGCTACATGAA-3Ј, TaqMan probe, 5Ј-(FAM)-nitro blue tetrazolium (Sigma). Immunoblots were per-TGGGCTTCGGCTGGGACCTTTC-(TAMRA)-3Ј].
formed in duplicate or triplicate on protein obtained from TaqMan probes for p21, p27 and p57 were purchased four to six separate experiments. Controls included omisfrom Synthegen (Houston, TX, USA). Primers and Taqsion of the primary or secondary antibodies; another transMan probe for GAPDH were obtained from TaqMan formed and late passage podocyte cell line was used as a rodent GAPDH control reagent (Applied Biosystems).
positive control for p57. India ink staining was used to The PCR conditions were: two minutes at 50ЊC, ten verify equivalent protein loading. minutes at 95ЊC, followed by 40 cycles at 95ЊC for 15 secStatistical analysis onds and 60ЊC for one minute. As a standard, a stock Statistical analysis on data obtained for BrdU staining cDNA made from RNA obtained from differentiating and densitometry was performed using analysis of vari-HSMP was serially diluted in tenfold steps in water from ance (ANOVA) with a Bonferroni-Dunn correction 250 nL to 250 pL. The standard curve was calculated (Statview; Abacus Concepts, Berkeley, CA, USA). A P based on the threshold cycles (Ct) values using Sequence value Ͻ0.05 was considered statistically significant. Detector 1.7 (Applied Biosystems) and relative mRNA quantity in each sample was determined based on its Ct RESULTS value. To normalize the quality and quantity of mRNA in each sample, p21, p27 and p57 mRNA levels were p57 was expressed in a specific spatial and temporal pattern during murine nephrogenesis, and is estimated as the ratio of p21/GAPDH, p27/GAPDH and constitutively expressed in mature podocytes p57/GAPDH. The results obtained from growth restrictive conditions are reported as the magnitude of increase To determine the localization and onset of p57 protein expression in podocytes, we began by examining the kidrelative to growth permissive conditions. Kip2 (p57) during murine glomerulogenesis. (A) The developing murine cortex at E15 displays glomeruli at all stages of maturation (ϫ200). p57 is absent in early glomerular structures including comma (example marked by C) and most S-shaped bodies (example marked by S). p57 is expressed strongly by cells at the capillary loop and maturational stages, and p57 expression is seen only in cells on the exterior of the capillary loops, consistent with developing podocytes. (B) High power view (ϫ630) of a glomeruli at the capillary loop stage showing intense nuclear staining for p57. (C) In maturational glomeruli at E18, p57 expression is segmental, a pattern which persists in adulthood (ϫ400). (D) Glomerulus from a normal adult mouse shows persistent staining for p57 in a podocyte distribution (ϫ1000).
neys of embryonic mice. Staining for p57 was not detected tures. BrdU staining was markedly diminished in glomeruli at the capillary loop and maturational stages, with in the early glomerular structures including vesicles and comma-shaped bodies (Fig. 1A) . Among S-shaped bodies virtually no BrdU positive cells detectable in a distribution consistent with podocytes (Fig. 2) . A similar pattern from all embryonic time points, Ͻ1% of cells exhibited faint staining for p57. In contrast, virtually all epithelia reof PCNA staining was observed at all embryonic time points and at days 1, 3, and 5 following birth. Thereafter, sembling primordial podocytes demonstrated intense nuclear staining for p57 at the capillary loop stage (Fig. 1A) .
PCNA staining diminished markedly, with rare PCNA positive cells detectable in the glomeruli of one-weekThere was strong nuclear staining for p57 in cells situated on the exterior of the capillary loops, in a distribution old mice. In biopsies of 14-day-old mice, PCNA was essentially restricted to renal tubular epithelia (results consistent with podocytes (Fig. 1B) . Segmental, but persistent intense immunostaining was observed in podonot shown). These results show that p57 and markers of DNA synthesis do not colocalize during glomerulogencytes of mature glomeruli (Fig. 1C) .
Immunohistochemical staining was also performed on esis, and suggest that p57 may be required for the decrease in podocyte DNA synthesis during development. kidneys from unmanipulated adult mice. Expression of p57 was not detected in mesangial, glomerular endothep57 alone was not required for normal lial, or parietal epithelial cells (Fig. 1D) . Although p57 glomerular maturation was not detected in every podocyte, the pattern of immunostaining for p57 was global, and present in the majority To determine the role for p57 in glomerular development, we examined kidneys from embryonic p57Ϫ/Ϫ of podocytes of every glomerulus. The pattern for p57 immunostaining was similar in podocytes of the adult and p57ϩ/ϩ mice. PAS staining on day 15 and day 18 kidneys showed that the histologic pattern of glomerulorat (Fig. 4A) .
genesis was similar in both mice, and that the kidneys p57 expression coincided with the cessation of DNA from p57Ϫ/Ϫ mice displayed normal glomeruli at all synthesis during glomerulogenesis stages of maturation, including capillary loop and mature forms (Fig. 3 ). There were no gross defects in podocyte To determine the colocalization of p57 and cell proliferation, murine embryonic tissue was stained for BrdU maturation detected on routine light microscopy, and there was no increase in glomerular cellularity in p57Ϫ/Ϫ and PCNA, markers of DNA synthesis, on serial sections alongside staining for p57. As shown in Figure 2 , the mice. To determine if the lack of p57 was associated with an increase in DNA synthesis, gravid mothers were staining pattern for BrdU was essentially reciprocal to that observed for p57. BrdU staining was most intense injected with BrdU prior to sacrifice. There were no differences in the pattern or intensity of glomerular imin the nephrogenic zone of the outer cortex, corresponding to the location of the most primitive glomerular strucmunostaining for either BrdU or PCNA in the p57Ϫ/Ϫ In contrast to BrdU, p57 staining is limited to cells that are BrdU negative (serial glomerulus shown by asterisks), and therefore not undergoing DNA synthesis (ϫ400). In mature glomeruli, p57 staining was in a typical podocyte distribution. embryonic mice compared to p57ϩ/ϩ embryonic mice of In the passive Heymann nephritis (PHN) model of experimental membranous nephropathy in the rat which the same gestational age (Fig. 3) . These results show that p57 is not essential for normal glomerular development.
is characterized by very low grade DNA synthesis, but without an increase in podocyte cell number [6] , complep57 expression decreased following injury in ment-induced injury to rat podocytes was associated with experimental glomerular diseases a diffuse and global decrease in the intensity of immunostaining for p57 at days 5 and 10 of PHN compared to Our results showed that p57 protein was expressed in normal adult mouse glomeruli and normal adult rat normal and control animals (Fig. 4 A, B ). There were no obvious differences in p57 staining in polyploid podoglomeruli, and that the localization was specific for podocytes. To determine if p57 protein levels are altered by cytes. Staining for p57 had normalized in podocytes by day 30 of PHN (results not shown). podocyte injury and if the levels of p57 are associated with changes in proliferation in mature podocytes, we
In the mouse, a model of immune-mediated glomerulonephritis characterized by occasional podocyte prolifstudied two models of experimental glomerular disease. eration in wild-type mice was studied [20, 34] . In contrast, cells incorporate BrdU. By five days of culture under differentiating conditions, the rate of DNA synthesis falls podocyte proliferation is marked in similarly injured p21Ϫ/Ϫ and p27Ϫ/Ϫ mice [20, 21] . Diseased mice were to 9 Ϯ 6% (P Ͻ 0.002 vs. cells pulsed under growth permissive conditions), which persists out to day 9. All cells sacrificed on day 7, the time of peak proliferation in this model [34] . Our results showed that p57 staining was grown under permissive and differentiating conditions stained for the Wilms tumor antigen (WT-1), a marker of uniformly absent in mouse podocytes localized to areas of epithelial cell proliferation. Furthermore, serial secboth developing and mature podocytes in vivo. In contrast, only cells grown under differentiating conditions tions revealed that p57 staining was not detectable in PCNA-positive epithelial cells (Fig. 4 C, D) . Moreover, stained for synaptopodin, a marker of mature podocytes, as previously reported (results not shown). in many glomeruli involved with epithelial proliferation, all murine podocytes appeared to have lost constitutive Quantitative real-time PCR was used to determine if the mRNA levels for p21, p27 and p57 were altered upon expression of p57 (Fig. 4 C, D) differentiation of conditionally immortalized mouse poDifferentiation and quiescence of cultured podocytes docytes. Figure 5 shows a representative result of the was associated with a differential expression of p57 real-time PCR and the standard curve that was gen-CDK-inhibitors erated. Standard curves were also determined for p21, p27 and GAPDH (data not shown) and mRNA expresTo determine if the changes observed in vivo were reproducible in vitro, we studied heat sensitive mouse posion in each sample was calculated using the standard curve. As shown in Figure 6A , the ratio of p21/GAPDH docytes in culture. As previously reported, these cells differentiate, arborize and cease to proliferate when increased in differentiating podocytes compared to undifferentiated podocytes, and the increase was 15.3-fold grown under certain conditions [37] . Consistent with previous reports [37] , analysis of BrdU staining confirmed in fully differentiated podocytes at day 8. The ratio of p27/GAPDH was only moderately increased (3.8-fold) that under growth permissive conditions, 50 Ϯ 11% of cells incorporate BrdU after a four-hour pulse. Three days in differentiating podocytes at day 3 and was 1.6-fold greater in fully differentiated podocytes at day 8 (Fig. after passage into differentiating conditions, 36 Ϯ 8% of early following the passage into differentiating conditions. However, there was an increase in p27 levels in differentiated podocytes on day 8.
In contrast to the Cip/Kip CDK-inhibitors p21 and p27, protein levels for p57 were barely detected in cultured podocytes by Western blot analysis (Fig. 7) . This was not a false negative, because p57 protein could be detected easily in the positive control protein, and this was verified by antibody absorption studies. Although we typically use 10 to 20 g of total podocyte protein lysate for Western analysis, we were still unable to detect significant amounts of p57 protein using 100 g of podocyte protein lysate. These findings were reproducible in duplicate blots performed on protein lysates obtained from four separate experiments.
Differentiation of heat-sensitive mouse podocytes was associated with a decrease in expression of cyclins and CDKs
Given the possible role of negative cell cycle regulators (CDK-inhibitors) to modulate the terminal differentiation of conditionally immortalized mouse podocytes, we sought to clarify whether positive cell cycle regulators also could regulate differentiation and proliferation. Therefore, Western blot analyses for cyclin A, cyclin B, and CDK2 was performed on cell lysates obtained at day 3 following passage in permissive conditions and at days 3 and 8 following passage into differentiating conditions (Fig. 8) . Our results showed that cyclin A, cyclin B, and CDK2 p57mRNA. (A) mRNA was harvested at day 8 growth restrictive conditions. cDNA was then generated by reverse transcription, and the cDNA protein were abundant under growth permissive condiwas diluted 1, 10, 100 and 1000 times for PCR reaction (represented tions. In contrast, after passage into differentiating condiby X1, X10, X100 and X1000 respectively). The PCR product of each tions, cyclin A expression was markedly decreased and dilution at each PCR cycle (X axis) was measured by the intensity of fluorescence (Y axis). Each experiment was performed in triplicate, cyclin B levels were undetectable. Cyclin D2 was detectand the curves at each dilution were superimposed. The results show able in low abundance under growth permissive condian exponential increase of fluorescent intensity was observed in certain tions. In contrast, D2 levels increased in differentiated ranges of PCR cycles. The threshold cycle (Ct) was determined using Sequence Detector 1.7. (B) A standard curve was generated for p57 podocytes, with peak expression demonstrable by the mRNA from the PCR result obtained from each dilution. The relative fully differentiated phenotype on day 8. CDK2 protein p57 mRNA quantity of each sample was calculated based on its Ct was present in proliferating cells, but the change to a value using this standard curve. The relative quantity of mRNA is shown on the X axis. differentiated phenotype coincided with a decrease in CDK2 levels. DISCUSSION 6B). Similar to p21, the ratio of p57/GAPDH was also increased progressively in differentiating podocytes, and
The mature podocyte has a limited proliferative capacwas 7.3-fold increased in fully differentiated podocytes ity, and the failure of injured podocytes to repopulate a at day 8 (Fig. 6C) .
denuded glomerular basement membrane (GBM) may Western blot analysis was used to detect the protein underlie the formation of tuft adhesions and progressive expression for p21, p27, and p57 from cells grown under glomerulosclerosis in certain diseases [1, 39, 40] . To degrowth permissive and differentiating conditions (Fig. lineate the mechanisms underlying these events further, 7). p21 was undetectable under growth permissive condithe current study focused on the CDK-inhibitor p57 betions. In contrast, p21 expression increased gradually in cause it is constitutively expressed in the normal pododifferentiated podocytes and was maximally expressed cyte in mice, rats and man [30] . Our results showed that in fully differentiated podocytes. p27 was expressed in despite the de novo increase in p57 protein expression during glomerulogenesis, p57Ϫ/Ϫ mice have normal glolow abundance under growth permissive conditions and merular morphology. Furthermore, we showed that p57 mRNA levels also increased in podocytes undergoing arborization and differentiation in vitro. Finally, immune-mediated injury to mature podocytes in experimental glomerular disease was associated with a decrease in p57 levels, but the loss of p57 alone was not sufficient to cause proliferation.
Our previous studies have focused on the role of the Cip/Kip CDK-inhibitors p21 and p27 in podocytes under normal and diseased states [19] [20] [21] . However, little is known about the role of p57 (the third member of the Cip/Kip family of CDK-inhibitors) in podocytes. Accordingly, we began this study by extending the work of Nagata and colleagues [31] and our previous studies [41] to determine if p57 was essential for podocyte development. Our data showed that the serial expression of p57 was most readily detected at the capillary loop stage, and that mature podocytes constitutively expressed p57. Interestingly, the loss of podocyte proliferative markers during development and the transition to the mature phenotype coincided with the onset of p57 protein expression. This descriptive data suggested that p57 is essential for normal glomerulogenesis. However, the first major finding in the current study was that p57Ϫ/Ϫ mice have normal glomerular morphology and, contrary to our expectation, p57Ϫ/Ϫ mice did not exhibit an increase in glomerular DNA synthesis or cell number. Unfortunately, because the majority of these mice die at birth from presumed non-renal causes [32, 42] , we did not have adequate numbers to assess glomerular development postnatally. Taken together, our data suggest that although p57 expression coincides with the acquisition of a mature phenotype, this CDK-inhibitor alone is not essential for podocyte development, whereas it is for other organs comprising the gastrointestinal and skeletal systems [32, 42, 43] . Moreover, our results show that within the kidney, there is a differential role for p57 in development, as Zhang has previously shown that p57 null mice develop medullary dysplasia [32] . Interestingly, although p21 and p27 also are expressed during glomerular development, p21 null [20] and p27 null mice [21] both have a normal glomerular architecture. Thus, the current and previous studies support the notion that individual members of the Cip/Kip family of CDK-inhibitors alone are not required for podocyte maturation. We await the histology of double CDK-inhibitor null mice.
In order to determine the potential role of specific CDK-inhibitors in podocyte differentiation in vitro and article also occurred in vitro, we studied a conditionally ingly increased at day 3 (D3) and day 8 (D8) of growth restrictive conditions (differentiating) compared to growth permissive podocytes at day 3 (D3). (B) The ratio of p27/GAPDH mRNA is moderately increased at day 3 and slightly increased at day 8 of growth restrictive conditions (differentiating) compared to growth permissive conditions conditions (differentiating) compared to permissive conditions. Realat day 3 (D3). (C) The ratio of p57/GAPDH mRNA is moderately time PCR was performed in triplicate. increased at day 3 and markedly increased at day 8 in growth restrictive Fig. 7 . Western blot analysis for CDK-inhibitors in cultured podocytes. Expression of p21 and p27 increase upon podocyte differentiation (20 g total protein in each lane). The protein levels of p57 were barely detected in differentiated podocytes (100 g total protein in each lane). A positive (ϩ) control using the same antibody is shown, indicating that the inability to detect a stronger band for p57 was not a false negative. of podocytes in vivo [37] . The second major finding in this ating conditions. Cyclin A, cyclin B, and CDK2 are all strongly expressed study was that the change in phenotype from a growth under permissive conditions and the protein levels were markedly reduced after passage into differentiating conditions. In contrast, Cyclin permissive one to an arborized and growth restrictive D2 expression increased after passage into differentiating conditions. phenotype was associated with increases in the mRNA levels for p21, p27 and p57. This was accompanied by an increase in protein levels for p21 and p27. Our results also showed that, in contrast to an increase in cyclin D2, proliferate was determined by the balance of Cip/Kip the switch to a mature phenotype in vitro was associated CDK-inhibitors, rather than p57 alone. Thus, in PHN with a decrease in cyclins A and B1, and CDK2. These rats, the transient and early decrease in p57 expression results show that podocyte differentiation in vitro inwas not associated with any marked increase in podocyte volves a complex interplay of cyclin-CDKs and specific proliferation. We have previously shown that the appar-CDK-inhibitors. Moreover, these results show that p57 ent inability of podocytes to proliferate in PHN rats was may not play a significant role in podocyte differentiation associated with an increase in p21 and p27 levels, and in vitro, a result similar to the in vivo studies. We can that decreasing p21 levels by administering the mitogen only speculate why p57 mRNA but not protein levels basic fibroblast growth factor (bFGF) was associated did not increase upon differentiation in vitro. One possiwith increased DNA synthesis [19] . In contrast, the inbility is increased p57 degradation. However, these recrease in podocyte proliferation in p21Ϫ/Ϫ [20] and sults should not be interpreted to imply that this is an p27Ϫ/Ϫ [21] mice with glomerulonephritis induced with invalid cell culture model, because previous studies have an anti-glomerular antibody was associated with a shown that heat-sensitive mouse podocytes have many marked decrease in p57 expression (unpublished data). features consistent with podocytes in vivo, and thus is a
We recently showed that p57 expression was not alvery useful model to further our understanding of podotered in human membranous nephropathy [30] . Our curcyte biology. rent study shows that there was an early and transient We [16] and others [31] have recently shown that p57 decrease in p57 in experimental membranous nephropais constitutively expressed in mature human podocytes. thy (PHN model), but the levels normalized within 30 To determine if p57 levels were altered by injury and if days after injury. Thus, the duration of disease may be this was associated with changes in the podocyte cell a plausible explanation accounting for the differences cycle, we studied two models of glomerular disease charin human and experimental membranous nephropathy. acterized by podocyte injury. The third major finding in Injecting mice with the anti-glomerular antibody dethis study was that injury to podocytes in experimental scribed is associated with an increase in podocyte prolifpassive Heymann nephritis (PHN) and in anti-glomerueration that results in layers of podocytes in association lar antibody induced glomerulonephritis was associated with collapse of the glomerular tuft. We recently showed with a decrease in p57 protein expression. However, our that the ability of podocytes to proliferate in human results showed that despite a decrease in p57 expression, glomerular disease correlates closely with p57 levels. In cellular and collapsing focal segmental glomerulonephrithe capacity of podocytes to re-engage the cell cycle and
